No documents were uploaded There are no additional links Consider on a case by case basis, collaborating on developing long acting products with potential significant public health impact, especially for low- and middle-income countries (LMICs), utilising the referred to long-acting technology Provide necessary technical information to a potential partner, under confidentiality agreement, to enable preliminary assessment of whether specific medicines of public health importance in LMICs might be compatible with the referred to long-acting technology to achieve a public health benefit In the event that a product using the referred to long-acting technology is successfully developed, the technology IP holder(s) will work with the Medicines Patent Pool towards putting in place the most appropriate strategy for timely and affordable access in low and middle-income countries, including through licensing
Effects of in ovo feeding of -aminobutyric acid on growth performances, plasma metabolites, and antioxidant status in broilers exposed to cyclic heat stress
Tr li: Thng thng, ngi dng s thy ci thin r rt sau 2 thng s dng u n
L-
The REMS requires that healthcare providers receive training and certification
It demonstrates greater efficacy in weight loss and metabolic improvements, compared to both semaglutide and tirzepatide
